The Myeloma Institute is at the forefront of research. With a dedicated faculty conducting clinical as well as basic science research, we are at the cutting edge of scientific breakthroughs.
Our internationally recognized physicians and scientists use state-of-the-art technologies to develop innovative treatments tailored to each patient’s specific disease.
The Myeloma Institute has received $10 million dollars to create the Bart Barlogie Center for Molecular Diagnostics and establish the Celgene Distinguished Endowed Chair in Molecular Therapeutics. Press Release.
Since 1989, our mission has been guided by one enduring principle: CURE. UAMS Myeloma Institute is a world leader in multiple myeloma research and treatment. Our team of dynamic scientists and clinicians translates advances from the laboratory into novel clinical treatments, continually expanding the boundaries of myeloma research and therapy toward cure for all patients.